State of the Art 2: Targeting the Non-T Cell Microenvironment

Moderator

Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium

Presentation numberSA2-01

Fibroblast and immunosuppression in breast cancer

Fatima Mechta-Grigoriou, Institut Curie, Paris, France

Presentation numberSA2-02

Role of macrophage reprograming in breast cancer outcomes

Lisa Coussens, Oregon Health & Science University, Portland, OR

Presentation numberSA2-03

Targeting non T-cells in the clinic

George Plitas, Memorial Sloan Kettering Cancer Center, New York, NY

Advocate

Cheryl Jernigan, PIVOT, University of Kansas Cancer Center, Kansas City, KS